IP Library Granted Patent US 11,197,964
Granted Patent B2
US 11,197,964 · App. 16/218,251 · Granted Dec 14, 2021

Pen cap for medication injection pen having temperature sensor

Inventors: John Sjolund (Los Altos, CA); Ambika Srinath (San Francisco, CA); Andrew Bochenko (Redwood City, CA); George Crothall (Oceanside, CA); Bryan Mazlish (Palo Alto, CA); Jennifer Martin Block (Menlo Park, CA); Sarah Matarese (Milpitas, CA); Linda Mackowiak (Cazenovia, NY); Lane Desborough (Thousand Oaks, CA)
Assignee: Bigfoot Biomedical, Inc.
A61M5/3202A61B5/0022A61B5/14532A61B5/746A61M2205/3317A61M2205/3368A61M2205/3553A61M2205/3569A61M2205/50A61M2205/505A61M2205/52A61M2230/201
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,197,964
App. No.
16/218,251
Granted
Dec 14, 2021
Kind
B2
Abstract

One or more embodiments of the disclosure relate, generally, to a replacement pen cap for a medication injection pen comprising at least one temperature sensor for monitoring a temperature of a medication, detect dosing events, and determine that medication may be denatured based on temperature data, received analyte measurement data prior, and the detected dosing events.

Claims (16)

1. A replacement pen cap for a medication injection pen comprising at least one temperature sensor configured to monitor a temperature of medication within the medication injection pen while the replacement pen cap is associated with the medication injection pen, wherein the replacement pen cap is configured to:

detect possible dosing events;

receive analyte measurement data from an analyte sensor system;

responsive to the received analyte measurement data, determine a relationship between the received analyte measurement data and an expected analyte measurement data due to the detected possible dosing events; and

determine, subsequent to at least one of the detected possible dosing events, if medication in the medication injection pen is denatured based at least partially on a combination of data from the at least one temperature sensor and the determined relationship between the received analyte measurement data and the expected analyte measurement data due to the detected possible dosing events.

2. The replacement pen cap of claim 1 , wherein the at least one temperature sensor is further configured to monitor ranges of temperature when the pen cap is associated with the medication injection pen.

3. The replacement pen cap of claim 1 , wherein the replacement pen cap is further configured to provide at least one of an alarm or alert to a user when a selected threshold temperature value is sensed, wherein an alert is presented when a threshold is exceeded as a visual display and an audible alarm is triggered when the threshold is exceeded and the received analyte measurement data indicates that one or more prior medication administrations have been ineffective.

4. The replacement pen cap of claim 3 , wherein glucose values are an interstitial fluid glucose level or based on an interstitial fluid glucose level.

5. The replacement pen cap of claim 3 , wherein glucose values are a blood glucose level correlated to an interstitial fluid glucose level.

6. The replacement pen cap of claim 3 , wherein glucose values are a blood glucose level.

7. The replacement pen cap of claim 1 , wherein the replacement pen cap is configured to provide data to a user relating to the temperature exposure of the medication.

8. A smart electronics module integratable with a medication injection pen comprising at least one temperature sensor configured to monitor a temperature of medication within the medication injection pen while the smart electronics module is enabled, wherein the smart electronics module is configured to:

detect possible dosing events;

receive analyte measurement data from an analyte sensor;

responsive to the received analyte measurement data, determine a relationship between the received analyte measurement data and an expected analyte measurement data due to the detected possible dosing events; and

determine, subsequent to at least one of the detected possible dosing events, if medication in the medication injection pen is denatured based at least partially on a combination of data from the at least one temperature sensor and the determined relationship between the received analyte measurement data and the expected analyte measurement data due to the detected possible dosing events.

Assignments (20)
RELEASE OF SECURITY INTEREST Recorded Jan 10, 2025
From: MADRYN FUND ADMINISTRATION, LLC
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 069870/0588 →
SECURITY INTEREST Recorded Jan 10, 2025
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069870/0519 →
SECURITY INTEREST Recorded Jan 10, 2025
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069870/0456 →
RELEASE OF SECURITY INTEREST Recorded Sep 30, 2024
From: MADRYN FUND ADMINISTRATION, LLC
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 069071/0980 →
SECURITY INTEREST Recorded Sep 30, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069073/0912 →
SECURITY INTEREST Recorded Sep 30, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069074/0001 →
SECURITY INTEREST Recorded Sep 24, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069030/0296 →
SECURITY INTEREST Recorded Sep 24, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069030/0104 →
RELEASE OF SECURITY INTEREST Recorded Sep 24, 2024
From: MADRYN FUND ADMINISTRATION, LLC
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 069030/0157 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 24, 2024
From: SJOLUND, JOHN; SRINATH, AMBIKA; BOCHENKO, ANDREW; CROTHALL, GEORGE; MAZLISH, BRYAN; BLOCK, JENNIFER MARTIN; MATARESE, SARAH; MACKOWIAK, LINDA; DESBOROUGH, LANE
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 068673/0194 →
SECURITY INTEREST Recorded Sep 23, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069019/0142 →
RELEASE OF SECURITY INTEREST Recorded Sep 23, 2024
From: MADRYN FUND ADMINISTRATION, LLC
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 069019/0346 →
SECURITY INTEREST Recorded Sep 23, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069019/0188 →
SECURITY INTEREST Recorded Sep 12, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 068948/0324 →
SECURITY INTEREST Recorded Sep 12, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 068948/0172 →
RELEASE OF SECURITY INTEREST Recorded Sep 12, 2024
From: MADRYN FUND ADMINISTRATION, LLC
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 068948/0377 →
RELEASE OF SECURITY INTEREST Recorded Sep 26, 2023
From: MADRYN FUND ADMINISTRATION, LLC
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 065029/0271 →
SECURITY INTEREST Recorded Feb 10, 2023
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 062702/0145 →
SECURITY INTEREST Recorded Mar 12, 2021
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 055583/0044 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 27, 2020
From: SJOLUND, JOHN; SRINATH, AMBIKA; BOCHENKO, ANDREW; CROTHALL, GEORGE; MAZLISH, BRYAN; BLOCK, JENNIFER MARTIN; MATARESE, SARAH; MACKOWIAK, LINDA; DESBOROUGH, LANE
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 052757/0871 →
Cited By (32)
US 12,296,139 US 12,303,667 US 12,303,668 US 12,318,577 US 12,343,502 US 12,370,307 US 12,370,309 US 12,383,166 US 12,406,760 US 12,431,229 US 12,485,223 US 12,495,994 US 12,496,398 US 12,514,979 US 12,514,980 US 12,521,486 US 12,551,619 US 12,551,621 US 12,558,026 US 12,562,251 US 12,564,679 US 12,569,619 US 12,592,306 US 12,636,435 US 12,646,601 US 12,651,659 US 12,653,426 US 12,653,949 US 12,667,665 US 12,691,221 US 12,691,222 US 12,708,709